-
Hepatocellular carcinoma (HCC) is the most
common type of
primary liver cancer in
adults and is
currently the most
common cause of
death in
people with...
-
Hepatocellular adenoma (also
known as
hepatic adenoma or hepadenoma) is a rare,
benign liver tumor. It most
commonly occurs in
people with
elevated systemic...
- common. FLC, also
known as
fibrolamellar hepatocellular carcinoma, is
different from the more
common hepatocellular carcinoma (HCC) in that it
afflicts young...
-
including Asia and sub-Saharan Africa.
Males are more
often affected with
hepatocellular carcinoma (HCC) than females.
Diagnosis is most
frequent among those...
-
categorize benign liver tumors is by
their anatomic source, such as
hepatocellular, biliary, or stromal.: 693–704
Cavernous hemangiomas (also
called hepatic...
-
vitamin K. A 1984
study first described the use of DCP as a
marker of
hepatocellular carcinoma (HCC); it was
present in 91% of HCC patients,
while not being...
-
analog of
cyclosporine A
developed for
nonalcoholic steatohepatitis and
hepatocellular carcinoma. Harrison,
Stephen A.; Mayo,
Patrick R.; Hobbs, Todd M.; Canizares...
-
longer period of time. Park et al.
conceptualized carcinogenesis of
hepatocellular carcinoma (HCC) as a
multistep process involving parenchymal arterialization...
-
following review presents the
benefits of
proton therapy in
treating hepatocellular carcinoma,
pancreatic cancer and
esophageal cancer. Post-treatment liver...
- drug is
being developed by Bristol-Myers
Squibb for the
treatment of
hepatocellular carcinoma or HCC (also
called malignant hepatoma), the most
common type...
